Detection of circulating tumor cells in breast cancer with a refined immunomagnetic nanoparticle enriched assay and nested-RT-PCR

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 9, Issue 7, 2013, Pages 1106-1113

  Li, Fu Rong ^a,b   Li, Qing ^a   Zhou, Han Xin ^c   Qi, Hui ^a   Deng, Chun Yan ^a  

^a JINAN UNIVERSITY   (China)

^b Shenzhen Institute of Gerontology   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

Author keywords

Breast cancer; Circulating tumor cells; Immunomagnetic nanoparticles; Nested RT PCR

Indexed keywords

BREAST CANCER; CIRCULATING TUMOR CELLS; IMMUNOCYTOCHEMISTRY; IMMUNOMAGNETIC; MAGNETIC NANO-PARTICLES; MICRO-PARTICLES; NESTED RT-PCR; TREATMENT MONITORING;

ASSAYS; CARBON; CELLS; DISEASES; MONOCLONAL ANTIBODIES; SURGERY;

NANOPARTICLES;

CARBON; CYTOKERATIN 19; EPITHELIAL CELL ADHESION MOLECULE; IMMUNOMAGNETIC NANOPARTICLE; IRON; MAGNETIC NANOPARTICLE; MAMMAGLOBIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD; BREAST CANCER; CANCER STAGING; CIRCULATING TUMOR CELL; CLINICAL EFFECTIVENESS; FALSE POSITIVE RESULT; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROMETASTASIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

BREAST CANCER; CIRCULATING TUMOR CELLS; IMMUNOMAGNETIC NANOPARTICLES; NESTED RT-PCR;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOMAGNETIC SEPARATION; KERATIN-19; MCF-7 CELLS; MIDDLE AGED; NANOPARTICLES; NEOPLASTIC CELLS, CIRCULATING; PARTICLE SIZE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84884283596     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.03.002     Document Type: Article

References (31)

1. Riethdorf S., Pantel K. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. Pathobiology 2008, 75:140-148.
2. Fehm T., Hoffmann O., Aktas B., Becker S., Solomayer E.F., Wallwiener D., et al. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Breast Cancer Res 2009, 11:R59.
3. Giordano A., Cristofanilli M. CTCs in metastatic breast cancer. Recent Results Cancer Res 2012, 195:193-201.
4. Alsamarai S., Abu-Khalaf M.M., Harris L.N. DTCs/CTCs in breast cancer: five decades later. Recent Results Cancer Res 2012, 195:217-225.
5. Lianidou E.S., Markou A. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Clin Chem 2011, 57:1242-1255.
6. Li Q., Qi H., Zhou H.X., Deng C.Y., Zhu H., Li J.F., et al. Detection of micrometastases in peripheral blood of non-small cell lung cancer with a refined immunomagnetic nanoparticle enrichment assay. Int J Nanomedicine 2011, 6:2175-2181.
7. Pachmann K., Clement J.H., Schneider C.P., Willen B., Camara O., Pachmann U., et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin Chem Lab Med 2005, 43:617-627.
8. Grünewald K., Haun M., Urbanek M., Fiegl M., Müller-Holzner E., Gunsilius E., et al. Mamaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19. Lab Invest 2000, 80:1071-1077.
9. Schindlbeck C., Stellwagen J., Jeschke U., Karsten U., Rack B., Janni W., et al. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen. Clin Exp Metastasis 2008, 25:233-240.
10. Stathopoulou A., Ntoulia M., Perraki M., Apostolaki S., Mavroudis D., Malamos N., et al. A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer. Int J Cancer 2006, 119:1654-1659.
11. Hüsemann Y., Geigl J.B., Schubert F., Musiani P., Meyer M., Burghart E., et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008, 13:58-68.
12. Smith B.L. Approaches to breast-cancer staging. N Engl J Med 2000, 342:508-581.
13. Xenidis N., Perraki M., Kafousi M., Apostolaki S., Bolonaki I., Stathopoulou A., et al. Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. J Clin Oncol 2006, 24:3756-3762.
14. Zheng S., Lin H., Liu J.Q., Balic M., Datar R., Cote R.J., et al. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A 2007, 1162:154-161.
15. Cruz I., Ciudad J., Cruz J.J., Ramos M., Gómez-Alonso A., Adansa J.C., et al. Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples. Am J Clin Pathol 2005, 123:66-74.
16. Simpson S.J., Vachula M., Kennedy M.J., Kaizer H., Coon J.S., Ghalie R., et al. Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry. Exp Hematol 1995, 23:1062-1068.
17. Pachmann K., Camara O., Kavallaris A., Krauspe S., Malarski N., Gajda M., et al. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol 2008, 26:1208-1215.
18. Ring A.E., Zabaglo L., Ormerod M.G., Smith I.E., Dowsett M. Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br J Cancer 2005, 92:906-912.
19. Serrano M.J., Rovira P.S., Martínez-Zubiaurre I., Rodriguez M.D., Fernández M., Lorente J.A. Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy. Exp Ther Med 2012, 4:43-48.
20. Went P.T., Lugli A., Meier S., Bundi M., Mirlacher M., Sauter G., Dirnhofer S. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004, 35:122-128.
21. Mostert B., Sleijfer S., Foekens J.A., Gratama J.W. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Cancer Treat Rev 2009, 35:463-474.
22. Cristofanilli M., Hayes D.F., Budd G.T., Ellis M.J., Stopeck A., Reuben J.M., et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005, 23:1420-1430.
23. Witzig T.E., Bossy B., Kimlinger T., Roche P.C., Ingle J.N., Grant C., et al. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin Cancer Res 2002, 8:1085-1091.
24. Allard W.J., Matera J., Miller M.C., Repollet M., Connelly M.C., Rao C., et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004, 10:6897-6904.
25. Choesmel V., Pierga J.Y., Nos C., Vincent-Salomon A., Sigal-Zafrani B., Thiery J.P., et al. Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance. Breast Cancer Res 2004, 6:R556-R570.
26. Cristofanilli M., Budd G.T., Ellis M.J., Stopeck A., Matera J., Miller M.C., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004, 351:781-791.
27. Riethdorf S., Fritsche H., Müller V., Rau T., Schindlbeck C., Rack B., et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the Cell Search system. Clin Cancer Res 2007, 13:920-928.
28. Gaforio J.J., Serrano M.J., Sanchez-Rovira P., Sirvent A., Delgado-Rodriguez M., Campos M., et al. Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis. Int J Cancer 2003, 107:984-990.
29. Bidard F.C., Mathiot C., Delaloge S., Brain E., Giachetti S., et al. Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann Oncol 2010, 21:729-733.
30. Riethdorf S., Müller V., Zhang L., Rau T., Loibl S., Komor M., et al. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clin Cancer Res 2010, 16:2634-2645.
31. Cristofanilli M., Budd G.T., Ellis M.J., Stopeck A., Matera J., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004, 351:781-791.